The Schmidt Firm, PLLC is actively handling methemoglobinemia lawsuits in all 50 states. If you or somebody you know used a benzocaine product and has been diagnosed with methemoglobinemia, you should contact us immediately. You may be entitled to compensation and our law firm can help.
June 5, 2012 — The FDA has issued a new consumer update to warn parents not to give benzocaine products to children under two years old, due to the risk of life-threatening methemoglobinemia. This life-threatening blood disorder can cause severe tissue damage, brain damage, and death. Products that contain benzocaine include, but are not limited to the following: Anbesol, Hurricaine, Orajel, Baby Orajel, and Orabase.
Benzocaine Topical Products: Sprays, Gels and Liquids: Risk of Methemoglobinemia
On April 7, 2011, the U.S. Food & Drug Administration (FDA) notified healthcare professionals and patients that it continues to receive reports of methemoglobinemia, a serious and potentially fatal adverse effect, in connection with benzocaine topical products. Consumers who use benzocaine products should follow the recommendations in the product label and talk to their healthcare professional about the risks vs. rewards of using benzocaine.
What is Methemoglobinemia?
Methemoglobinemia occurs when the amount of oxygen carried through the blood stream is greatly reduced. Signs and symptoms typically appear within minutes to hours after application and include:
- pale, gray or blue colored skin, lips, and nail beds
- shortness of breath
- rapid heart rate
Methemoglobinemia has been reported with all strengths of benzocaine gels and liquids, and cases occurred mainly in children aged two years or younger who were treated with benzocaine gel for teething. It is still not clearly understood whether the development of methemoglobinemia after treatment with benzocaine sprays is related to the amount applied. In many cases, methemoglobinemia was reported following the administration of a single benzocaine spray.
Do I Have a Benzocaine Lawsuit?
Our attorneys are currently accepting benzocaine cases in all 50 states. If you or somebody you know used a benzocaine product and has been diagnosed with methemoglobinemia, you should contact us immediately. You may be entitled to compensation and we can help. Please use the form below to contact our Defective Drug & Products Liability Litigation Group or call toll free 24 hours a day at (866) 920-0753.
Attention Lawyers: We consider a referral from another law firm to be one of the greatest compliments. If your firm is interested in referring us your case or for us to send you a list of previous award judgments and/or average referral fees, please visit the Lawyer Referral section of our website.